158 Samji: Influenza A: understanding the viral life cycle of mRNA strongly influence its ability to act as primer for influenza virus RNA transcrip- tion. Proc Natl Acad Sci USA. 1980;77(7):3952-6. 25. Krug RM, Broni BA, Bouloy M. Are the 5' ends of influenza viral mRNAs synthesized in vivo donated by host mRNAs? Cell. 1979;18(2):329-34. 26. Robertson HD, Dickson E, Plotch SJ, Krug RM. Identification of the RNA region trans- ferred from a representative primer, beta-glo- bin mRNA, to influenza mRNA during in vitro transcription. Nucleic Acids Res. 1980;8(5):925-42. 27. Li ML, Rao P, Krug RM. The active sites of the influenza cap-dependent endonuclease are on different polymerase subunits. EMBO J. 2001;20(8):2078-86. 28. Engelhardt OG, Smith M, Fodor E. Associa- tion of the influenza A virus RNA-dependent RNA polymerase with cellular RNA poly- merase II. J Virol. 2005;79(9):5812-8. 29. Amorim MJ, Digard P. Influenza A virus and the cell nucleus. Vaccine. 2006;24(44- 46):6651-5. 30. Engelhardt OG, Fodor E. Functional associ- ation between viral and cellular transcription during influenza virus infection. Rev Med Virol. 2006;16(5):329-45. 31. Lu Y, Qian XY, Krug RM. The influenza virus NS1 protein: a novel inhibitor of pre-mRNA splicing. Genes Dev. 1994;8(15):1817-28. 32. Wang W, Krug RM. U6atac snRNA, the highly divergent counterpart of U6 snRNA, is the specific target that mediates inhibition of AT-AC splicing by the influenza virus NS1 protein. RNA. 1998;4(1):55-64. 33. Fortes P, Lamond AI, Ortin J. Influenza virus NS1 protein alters the subnuclear localization of cellular splicing components. J Gen Virol. 1995;76(Pt 4):1001-7. 34. Wolff T, O'Neill RE, Palese P. NS1-Binding protein (NS1-BP): a novel human protein that interacts with the influenza A virus nonstruc- tural NS1 protein is relocalized in the nuclei of infected cells. J Virol. 1998;72(9):7170-80. 35. Momose F, Basler CF, O'Neill RE, Iwamatsu A, Palese P, Nagata K. Cellular splicing fac- tor RAF-2p48/NPI-5/BAT1/UAP56 interacts with the influenza virus nucleoprotein and enhances viral RNA synthesis. J Virol. 2001;75(4):1899-908. 36. Fodor E, Pritlove DC, Brownlee GG. The in- fluenza virus panhandle is involved in the initia- tion of transcription. J Virol. 1994;68(6):4092-6. 37. Hagen M, Chung TD, Butcher JA, Krystal M. Recombinant influenza virus polymerase: re- quirement of both 5' and 3' viral ends for endonu- clease activity. J Virol. 1994;68(3):1509-15. 38. Robertson JS, Schubert M, Lazzarini RA. Polyadenylation sites for influenza virus mRNA. J Virol. 1981;38(1):157-63. 39. Poon LL, Fodor E, Brownlee GG. Polyuridy- lated mRNA synthesized by a recombinant influenza virus is defective in nuclear export. J Virol. 2000;74(1):418-27. 40. Poon LL, Pritlove DC, Fodor E, Brownlee GG. Direct evidence that the poly(A) tail of influenza A virus mRNA is synthesized by re- iterative copying of a U track in the virion RNA template. J Virol. 1999;73(4):3473-6. 41. Shimizu K, Iguchi A, Gomyou R, Ono Y. In- fluenza virus inhibits cleavage of the HSP70 pre-mRNAs at the polyadenylation site. Vi- rology. 1999;254(2):213-9. 42. Nemeroff ME, Barabino SM, Li Y, Keller W, Krug RM. Influenza virus NS1 protein inter- acts with the cellular 30 kDa subunit of CPSF and inhibits 3'end formation of cellular pre- mRNAs. Mol Cell. 1998;1(7):991-1000. 43. Chen Z, Li Y, Krug RM. Influenza A virus NS1 protein targets poly(A)-binding protein II of the cellular 3'-end processing machinery. EMBO J. 1999;18(8):2273-83. 44. Shapiro GI, Gurney T Jr., Krug RM. In- fluenza virus gene expression: control mech- anisms at early and late times of infection and nuclear-cytoplasmic transport of virus-spe- cific RNAs. J Virol. 1987;61(3):764-73. 45. Akarsu H, Burmeister WP, Petosa C, Petit I, Muller CW, Ruigrok RW, Baudin F. Crystal structure of the M1 protein-binding domain of the influenza A virus nuclear export protein (NEP/NS2). EMBO J. 2003;22(18):4646-55. 46. Baudin F, Petit I, Weissenhorn W, Ruigrok RW. In vitro dissection of the membrane and RNP binding activities of influenza virus M1 protein. Virology. 2001;281(1):102-8. 47. Loucaides EM, von Kirchbach JC, Foeglein A, Sharps J, Fodor E, Digard P. Nuclear dy- namics of influenza A virus ribonucleopro- teins revealed by live-cell imaging studies. Virology. 2009;394(1):154-63. 48. Elton D, Amorim MJ, Medcalf L, Digard P. 'Genome gating'; polarized intranuclear traf- ficking of influenza virus RNPs. Biol Lett. 2005;1(2):113-7. 49. Iwatsuki-Horimoto K, Horimoto T, Noda T, Kiso M, Maeda J, Watanabe S, et al. The cy- toplasmic tail of the influenza A virus M2 protein plays a role in viral assembly. J Virol. 2006;80(11):5233-40. 50. Burleigh LM, Calder LJ, Skehel JJ, Stein- hauer DA. Influenza a viruses with mutations in the m1 helix six domain display a wide va- riety of morphological phenotypes. J Virol. 2005;79(2):1262-70. 51. Chen BJ, Lamb RA. Mechanisms for enveloped virus budding: can some viruses do without an ESCRT? Virology. 2008;372(2):221-32. 52. Enami M, Sharma G, Benham C, Palese P. An influenza virus containing nine different RNA segments. Virology. 1991;185(1):291-8. 53. Bancroft CT, Parslow TG. Evidence for seg- ment-nonspecific packaging of the influenza a virus genome. J Virol. 2002;76(14):7133-9. 54. Smith GL, Hay AJ. Replication of the in- fluenza virus genome. Virology. 1982;118(1):96-108.